Minerva Neurosciences Inc

Gesloten

4.8 -4.57

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.79

Max

5.07

Belangrijke statistieken

By Trading Economics

Inkomsten

158M

-125M

K/W

Sectorgemiddelde

2.462

56.269

EPS

-0.36

Werknemers

7

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+105.88% upside

Dividenden

By Acuity

Volgende Winsten

12 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

33M

218M

Vorige openingsprijs

9.37

Vorige sluitingsprijs

4.8

Minerva Neurosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 jul 2026, 23:51 UTC

Bitcoin and Ethereum rise as weak U.S. jobs data dims Fed rate hike expectations, while Asian markets react positively to easing geopolitical tensions.

5 jul 2026, 23:51 UTC

Bitcoin and Ethereum see positive returns amid weak U.S. jobs data and stable Eurozone activity, while geopolitical tensions ease.

5 jul 2026, 23:51 UTC

Bitcoin and Ethereum rise as U.S. jobs data dims Fed rate hike expectations ahead of key FOMC minutes release.

5 jul 2026, 23:51 UTC

Disappointing U.S. jobs report dampens interest rate hike expectations, impacting investor sentiment and market stability ahead of key economic releases.

5 jul 2026, 23:51 UTC

ISM Services PMI Forecasted at 54.2 Indicates Continued Growth Amid Economic Uncertainties and Potential Fed Policy Shifts

5 jul 2026, 23:51 UTC

Correlated Moves

Bitcoin is trading higher during Sunday’s session, continuing its upward trajectory since Saturday's close. The asset remains above its 20-day moving average.

5 jul 2026, 23:41 UTC

Canada's Full-Time Employment Change Data Release on July 10 Sparks Market Focus Amid Economic Uncertainty and Government Initiatives.

5 jul 2026, 23:41 UTC

Canada's Part-Time Employment Change Data Release on July 10, 2026, Could Signal Economic Health Amid Government Policy Announcements.

5 jul 2026, 23:41 UTC

Canada's unemployment rate data release on July 10, 2026, expected to show slight improvement at 6.6%, amid mixed signals in job growth and inflation concerns impacting monetary policy.

5 jul 2026, 23:41 UTC

Canada's Employment Change Report Forecasts 10,000 Job Increase Amid Mixed Market Sentiment and Economic Challenges

5 jul 2026, 23:41 UTC

Canada's Labor Force Participation Rate Release Amid Growing Concerns Over Job Security Due to AI and Automation

5 jul 2026, 23:31 UTC

Macro News
Correlated Moves

Silver prices are rising, supported by a recovery in gold and recent oil supply increases. The U.S. dollar's strength may limit upward momentum.

5 jul 2026, 23:31 UTC

Correlated Moves

XRP is trading roughly flat amid broader market sentiment, with Bitcoin moving moderately. The cumulative price change since Saturday remains minimal.

5 jul 2026, 23:22 UTC

U.S. Exports Data Release on July 7, 2026, Expected to Reflect Strong Performance Amid Trade Tensions and Inflationary Pressures

5 jul 2026, 23:22 UTC

U.S. Balance of Trade report on July 7 forecasts a $78.8 billion deficit, raising concerns over persistent trade imbalances and potential impacts on monetary policy amid cautious market sentiment.

5 jul 2026, 23:22 UTC

U.S. Imports Data Release on July 7 Expected to Show Continued Growth Amid Tariff Impacts and Supply Chain Adjustments

5 jul 2026, 23:22 UTC

Brazil's July 10 inflation rate release draws market attention amid global economic concerns and potential volatility.

5 jul 2026, 23:22 UTC

Mexico's July Inflation Rate Release Expected to Show Stabilization Around 3.94%, Influencing Future Banxico Policy Decisions

5 jul 2026, 23:22 UTC

Brazil's June Inflation Rate Expected to Rise, Heightening Market Volatility Ahead of July 10 Release

5 jul 2026, 23:22 UTC

Mexico's June Inflation Rate Release on July 9 Expected to Influence Monetary Policy Amid Global Economic Concerns.

5 jul 2026, 23:22 UTC

Canada's Balance of Trade data set for July 7, 2026, anticipates a C$2.4 billion surplus amid strong export activity and cautious optimism despite global uncertainties.

5 jul 2026, 23:11 UTC

USD/HKD is trading roughly flat after-market, with no specific news identified. Anticipation surrounds upcoming FOMC minutes and inflation data.

5 jul 2026, 23:02 UTC

Macro News
Correlated Moves

The U.S. dollar has recovered against the Canadian dollar, leading to a slight gain in USD/CAD after-market trading.

5 jul 2026, 23:02 UTC

Gold and silver are trading lower during Sunday’s session, continuing a downward trend since Friday's close. Market participants await key economic data.

5 jul 2026, 23:01 UTC

Correlated Moves

Silver/AUD is trading higher, supported by gold's gains and reduced interest rate hike expectations following weaker job growth data.

5 jul 2026, 23:01 UTC

Correlated Moves

Gold/NZD is trading higher, supported by rising gold prices against the U.S. dollar and market volatility ahead of key economic data releases.

5 jul 2026, 23:01 UTC

Correlated Moves

Silver/GBP is trading higher, reflecting gains in gold prices. The recent trend includes four consecutive sessions of closing higher.

5 jul 2026, 23:01 UTC

Correlated Moves

Silver/CHF is trading higher, reflecting gains from correlated movements in gold. The upward trend continues after four consecutive sessions of increases.

5 jul 2026, 23:01 UTC

Correlated Moves

Gold/HKD is higher, supported by positive market sentiment and a rise in silver. Weaker job growth data has reduced expectations for immediate interest rate hikes.

5 jul 2026, 23:01 UTC

Correlated Moves

Silver/CAD is higher, reflecting gains alongside rising gold prices. The asset has seen four consecutive sessions of higher closes amid significant volatility.

Peer Vergelijking

Prijswijziging

Minerva Neurosciences Inc Prognose

Koersdoel

By TipRanks

105.88% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 10.5 USD  105.88%

Hoogste 14 USD

Laagste 7 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Minerva Neurosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Winst voor belastingen

Verkoop

Rente-uitgaven op schulden

Operationele winst

$

Over Minerva Neurosciences Inc

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
help-icon Live chat